Doctors Join Call To Regulate Intoxicating Hemp Cannabinoids

Doctors Join Call To Regulate Intoxicating Hemp Cannabinoids

A professional organization of physicians who support drug policy reform is calling for the regulation of intoxicating cannabinoids derived from hemp, including delta-8 THC, arguing that the safety of products containing the compound is unknown. This recommendation was recently made by Physicians for Drug Policy Reform (D4DPR), a group of medical experts formerly known as Physicians for Cannabis Regulation.

“Our position at D4DPR is that all intoxicating cannabinoids should be subject to a regulatory framework to ensure public safety,” the group wrote in a letter. policy document It was released this month.

In their paper, D4DPR notes that the legalization of hemp in the 2018 Farm Bill would allow “hemp-derived cannabidiol (CBD) and other phytocannabinoids (obtained directly from the plant) to become more addictive than delta cannabinoids.” It is possible that the chemical conversion of some into minor cannabinoids was inadvertently legalized.” 8-tetrahydrocannabinol (Δ8-THC, also known as delta-8).'' However, this law did not include provisions regulating cannabis-derived cannabinoids, which are unregulated in many jurisdictions. This led to a flourishing industry of products containing intoxicating compounds.

“Taking advantage of this opportunity, Δ8-THC (chemically synthesized from hemp CBD) is now readily available at various retail outlets such as gas stations, CBD shops, convenience stores, smoke shops, and online platforms. ” the group said in their paper. . “Currently, several states have banned or imposed restrictions on its sale. However, in 22 states (as of November 2023), Δ8-THC remains legal and unregulated and cannot be used in clinical testing. Taxation is limited, there are no warnings about intoxicating effects, there are no dosage restrictions, and it is easily available to minors.”

To address this issue, D4DPR called on policymakers to develop and enact a regulatory framework for all intoxicating cannabinoids, regardless of their source. The group included several regulatory recommendations, including a provision that would allow intoxicating compounds to be sold only by licensed pharmacies. The group also called for “appropriate taxation” to fund public health efforts and regulatory oversight of the cannabinoid market.

The group also recommended limiting the sale of intoxicating cannabinoids to adults 21 and older. The recommendations require that intoxicating hemp products be sold only in child-proof packaging that is not attractive to minors, with clear labeling of the product's intoxicating properties. The packaging must also include the International Intoxicating Cannabinoid Product Symbol (a silhouette of a cannabis leaf) to indicate the contents in graphic form.

The recommendation also requires laboratory testing of intoxicating cannabinoid products for purity, potency, and safety, and requires that certificates of analysis be made available for consumer inspection. The group also recommended conducting clinical safety and toxicology studies of minor cannabinoids, noting that many of the compounds are new to the market.

D4DPR also recommended that regulations regarding intoxicating cannabinoids be consistent with those in place in states with medical marijuana and adult-use cannabis programs, and that states without such regulations develop regulations as soon as possible. The group also called for a rescheduling of cannabis use at the federal level, noting that banning intoxicating and mild cannabinoids would “enable the continuation of the war on drugs and have negative public health consequences.”

“This policy stance reflects our commitment to protect public health while ensuring reasonable access to cannabis and hemp-derived products within a responsible regulatory framework.” concluded in writing.

The D4DPR policy document joins a chorus of calls to regulate intoxicating cannabinoids. Last month, 21 state attorneys general sent a letter to Congressional leaders asking them to “address the apparent ambiguities that arose in the 2018 Farm Bill.”

“The reality is that this law will leave us with a plethora of unregulated products with incredible levels of potency, in the form of candy that appeals to young people and children, that are nothing but more potent cannabis.” are being unleashed on the state. There is no oversight and our office's ability to contain them is limited.” they wrote in a letter.

David B.
David B. stands out as an exceptional cannabis writer, skillfully navigating the intricate world of cannabis culture and industry. His insightful and well-researched articles provide a nuanced perspective on various aspects, from the therapeutic benefits to the evolving legal landscape. David's writing reflects a deep understanding of the plant's history, its diverse strains, and the ever-changing dynamics within the cannabis community. What sets him apart is his ability to break down complex topics into digestible pieces, making the information accessible to both seasoned enthusiasts and newcomers alike. With a keen eye for detail and a passion for the subject, David B. emerges as a reliable and engaging voice in the realm of cannabis literature.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *